Duke’s Office for Translation & Commercialization works with Duke innovators to get their inventions out of the university and into the market with maximal societal impact. Visit website.
News from Duke OTC | |
 | 10 Years, 60 Startups, $105 Million - and Counting: Duke Capital Partners Leads the Way in Alumni Investing Published March 28, 2025 |
| VQ Biomedical secures $5M, including a seed round led by Harbright, WIN, and DCP Published March 27, 2025 |
| Colleagues off the Court: Duke and UNC Champion Research and Innovation on Capitol Hill Published March 24, 2025 |
| Duke University ranks 24th worldwide for patents granted to academic institutions Published March 11, 2025 |
| Interdisciplinarity and impact shine at Duke Research and Innovation Summit 2025 Published January 14, 2025 |
| Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs Published January 13, 2025 |
| Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platfo Published January 8, 2025 |
